Mental Health Centre Copenhagen
Copenhagen, Denmark
NCT Number: NCT03113175
The aim of the study Collabri Flex is to:
* Develop a Danish model for collaborative care for patients with anxiety in general practice, based on past experience gained in the Collabri Project. * Examine the impact of this model compared with liaison-consultation for people with anxiety in a randomized controlled design from selected endpoints.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Copenhagen, Denmark
The Collabri Flex model for Collaborative Care takes point of departure in the earlier study Collabri. It is changed according to gathered information under the first study of the Collabri model in order to achieve a Danish Collaborative Care model easier to implement.
The aims of Project Collabri Flex are to:
In Collabri the treatment is in line with a set of general treatment principles relevant for collaborative care interventions. The patients in the intervention group are offered cognitive behavioral therapy (CBT), psychoeducation and medication according to at stepped care model by a care manager refering to the general practitioner.
The Collabri Flex study is set up as a researcher-blinded individually randomized controlled trial with participation of an intervention group (treatment according to the Collabri Flex model) and a consultation liaison group.
This study will contribute with new knowledge on collaborative care interventions in a Scandinavian context.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
For patients in the Collabri Flex group:
Collaborative care provided by the general practitioner and the care manager. Treatment modalities: Cognitive-behavior Therapy, psychoeducation, medication according to a stepped care model
Consultation-Liaison provided by general practitioner involving a educational relationship with the Collabri Flex team (care manager and psychiatrist).
Time frame: 6 months
Measured by Beck Anxiety Inventory (BAI)
Time frame: 6 months
Measured by Beck Depression Inventory (BDI-II)
Time frame: 6 months
Measured by the Symptom Checklist SCL-90-R
Time frame: 6 months
Measured by Sheehan Disability Scale (SDS)
Time frame: 6 months
Measured by WHO-5
Time frame: 6 months
Obtained from the DREAM database
Time frame: 18 months
Obtained from the DREAM database
Time frame: 6 months
Measured by the IPQ-R Scale (Personal control) and two subscales from the Chronic disease Selv-Efficacy Scales (SECD-32); Obtain help from Community, Family, Friends Scale and control Manage Depression Scale
Time frame: 18 months
Measured by the IPQ-R Scale (Personal control) and two subscales from the Chronic disease Selv-Efficacy Scales (SECD-32); Obtain help from Community, Family, Friends Scale and control Manage Depression Scale
Time frame: 6 months
Measured by EQ-5D
Time frame: 18 months
Measured by EQ-5D
Time frame: 6 months
Obtained from the DREAM database
Time frame: 18 months
Obtained from the DREAM database
Time frame: 6 months
National patient register
Time frame: 18 months
National patient register
Time frame: 6 months
Self-reported support in recovery (INSPIRE)
Time frame: 6 months
Self-reported satisfaction with treatment (CSQ-8)
Time frame: 18 months
Measured by Beck Anxiety Inventory (BAI)
Time frame: 18 months
Measured by Beck Depression Inventory (BDI-II)
Time frame: 18 months
Measured by the Symptom Checklist SCL-90-R
Time frame: 18 months
Measured by Sheehan Disability Scale (SDS)
Time frame: 18 months
Measured by WHO-5
Amager Hospital
Other
Project Collabri Flex - The Effect of a Danish Model for Collaborative Care for People With Anxiety and Depression in General Practice
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03206437
Agoraphobia, Anxiety Disorders
Washington D.C., District of Columbia, United States
View Trial DetailsNCT03143634
Agoraphobia, Anxiety Disorders
Cambridge, United Kingdom
View Trial DetailsNCT07129408
Agoraphobia, Alcohol Addiction
Bratislava, Slovakia
View Trial DetailsNCT03051074
Agoraphobia, Anxiety Disorders
Tulsa, Oklahoma, United States
View Trial Details